Metraipolis › archive › dc_3badcc2d8912
Bezafibrate-associated rhabdomyolysis in a patient with diabetic kidney disease: A case report and successful transition to tafolecimab — Europe PMC PMID:42332483
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42332483
- DOI
- 10.1097/md.0000000000049269
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T23:33:07.551Z
- SHA-256 of the archived text
469d40989e18c474e2675880fcddbbf367fbf8d0b0bf9e7488ad960c731bd6e9- Stable URL of this page
https://metraipolis.com/documento/dc_3badcc2d8912
How to cite
Bezafibrate-associated rhabdomyolysis in a patient with diabetic kidney disease: A case report and successful transition to tafolecimab — Europe PMC PMID:42332483 — Europe PMC (en), https://europepmc.org/article/MED/42332483 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3badcc2d8912 (Metraipolis archive dc_3badcc2d8912, sha256 469d40989e18c474e2675880fcddbbf367fbf8d0b0bf9e7488ad960c731bd6e9)
BibTeX
@misc{dc3badcc2d8912,
title = {Bezafibrate-associated rhabdomyolysis in a patient with diabetic kidney disease: A case report and successful transition to tafolecimab — Europe PMC PMID:42332483},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42332483},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3badcc2d8912; sha256 469d40989e18c474e2675880fcddbbf367fbf8d0b0bf9e7488ad960c731bd6e9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42332483. Agents can read the archived copy with the MCP tool read_document.